Aprogen Biologics Inc. (003060.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 102.98B |
| Enterprise Value | 303.91B |
| P/E Ratio | -0.21 |
| PEG Ratio | -0.5 |
| Price/Sales Ratio | 0.35 |
| Price/Book Ratio | 0.13 |
| Enterprise/Revenue | 2.96 |
| Enterprise/EBITDA | -2.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.68 |
| Operating Margin | -1.58 |
AD
Management Effectiveness
| Return On Assets | -0.23 |
| Return On Equity | -0.57 |
Income Statement
| Revenue | 73.23B |
| Revenue/Share | 5,921.53 |
| Gross Profit | -28.42B |
| EBITDA | -103.7B |
| Net Income | -170.33B |
| Diluted EPS | -12,931 |
Balance Sheet
| Total Cash | 50.1B |
| Total Cash/Share | 3,803.64 |
| Total Debt | 227.15B |
| Total Debt/Equity | 1.12 |
| Current Ratio | 0.67 |
| Book Value Per Share | 20,974.16 |
Price History
| 52-Week Change | -78.15 |
| 52-Week High | 10,719.64 |
| 52-Week Low | 2,010 |
| Moving Average 50 Days | 3,376.11 |
| Moving Average 200 Days | 6,455.57 |
Statistics
| Average Volume | 294,534 |
| Shares Outstanding | 13.18M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 667:10000 |
| Last Split Date | April 13, 2026 |
AD
